PMB and Montgomery Street Partners announce approval on the first speculative purpose-built life sciences project in Boulder County, CO

This new 365,000 sq. ft. facility in Boulder County will break ground in Q2 of 2023 and complete in Q3 of 2024 PMB, a leading healthcare real estate developer, in partnership with Montgomery Street Pa...

Learn More

Think Bioscience Raises $17M in Oversubscribed Seed Round to Develop Small Molecule Drugs that Hit Undruggable Proteins

Funding will enable Think Bioscience to expand its drug discovery platform and advance its internal drug development programs.  Think Bioscience (“Think”), a synthetic biology company focuse...

Learn More

HepQuant Awarded COLA Accreditation for meeting US Clinical Laboratory Improvement Act (CLIA) and other Regulatory Requirements

HepQuant, LLC,  a Denver, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced that the HepQuan...

Learn More

AGC Biologics Supports Altheia Science’s Gene Therapy Programs

AGC Biologics, today, announced a new partnership with Altheia Science. Through this partnership, Altheia Science will advance its development of autoimmunity treatments, focused on modulati...

Learn More

Terumo Blood and Cell Technologies collaborates with Eliaz Therapeutics in the development and commercialization of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

Acute kidney injury (AKI) and sepsis-induced acute kidney injury (S-AKI) are life-threatening conditions, with many patients dying and others left with long-term kidney damage requiring lifelong dialy...

Learn More

SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay

SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire Palamedrix, Inc., an innovator in DNA nanotechnology. Palamedrix pro...

Learn More

Cerebral Therapeutics, Inc. Secures $40 Million Series C Financing

Cerebral Therapeutics, a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today $40 million in Series C funding led by Lynx1 Capital Management with part...

Learn More

Weekly Policy Update: Senate Prescription Drug Pricing Legislation

Democrats in the U.S. Senate continue to negotiate an economic package that advances President Joe Biden’s key priorities. Prescription drug pricing legislation that would drastically alter the Medica...

Learn More

Securisyn Medical Announces Strategic Manufacturing and Distribution Partnership with SunMed Group Holdings

Securisyn Medical LLC, (“Securisyn” or the “Company”), an emerging medical device company dedicated to enhancing ventilated patient safety and broader smooth tube and catheter securement, and SunMed G...

Learn More

Philips Incorporates Biodesix Blood-based Proteomic Nodule Risk Assessment Testing into Lung Cancer Orchestrator to Advance Early Lung Cancer Diagnosis

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has teamed up with Biodesix, Inc. (Colorado, U.S.) (Nasdaq: BDSX), a leading data-dri...

Learn More